Torun Labedzki is now serving in a new position at A1M Pharma AB

Aug 29, 2019
Board and Executive Moves
Background Information
Chief Financial Officer at A1M Pharma AB
Guard Therapeutics International AB engages in the research, development, and commercialization of medical treatment and diagnosis based on alpha-1-microglobulin. It focuses on the treatment of pre-eclampsia and acute kidney injury. The company was founded by Bo Åkerström, Tomas Jörgen Eriksson, Stefan Hansson, Gram Magnus on April 4, 2008 and is headquartered in Lund, Sweden.